Journal article
Assessment of specific immunotherapy efficacy using a novel placebo score–based method
Abstract
BACKGROUND: In trials of allergen immunotherapy, allergen exposure is typically assessed by pollen counts, but these may misrepresent exposure if performed remotely from multiple study centers.
OBJECTIVE: To assess whether symptomatology in placebo-treated patients is a better measure of local allergen burden at individual centers in such trials.
Authors
Frew AJ; DuBuske L; Keith PK; Corrigan CJ; Aberer W; von Weikersthal-Drachenberg KJF
Journal
Annals of Allergy Asthma & Immunology, Vol. 109, No. 5, pp. 342–347.e1
Publisher
Elsevier
Publication Date
11 2012
DOI
10.1016/j.anai.2012.08.013
ISSN
1081-1206